BOT 4.35% 36.0¢ botanix pharmaceuticals ltd

Ann: BTX 1702 Rosacea Study Approval, page-55

  1. 1,072 Posts.
    lightbulb Created with Sketch. 474
    Back to penny stock status ... this stock never ceases to amaze me.

    already in the bottom draw ... ho hum.

    don’t even bother keeping track of it at the moment .... just a perpetually unsexy stock .... bad news lose half, awesome news lose 40% .... unfortunately until the pay day comes .... and it will ... just best to ignore this rubbish.

    stay in and put in the bottom draw and be rewarded in the next year or two or get out and seek better opportunities.

    Me I’m in, but am making money day trading at the moment.

    no point even looking at this as there is just no big news coming up for a while.

    only possible game changer is a partnership or something a long those lines.

    GLLTH it’s been a tough ride since antimicrobial
    results. Not to mention a baffling one.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.015(4.35%)
Mkt cap ! $651.6M
Open High Low Value Volume
34.5¢ 36.5¢ 34.5¢ $1.108M 3.101M

Buyers (Bids)

No. Vol. Price($)
16 48289 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 503480 21
View Market Depth
Last trade - 14.28pm 22/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.